Patent · US Active

Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies

US8361974B2 · kind B2 · utility

8Cited by

4References

12Claims

0Family size

Assignee

Galderma Holding SA · CH

Inventors

Alexandre KAOUKHOV · Newport Beach, US
Christophe Villard · Le Tignet, FR
Philippe BOUISSOU · Valbonne, FR

Key dates

Filing date	Jun 14, 2011
Grant date	Jan 29, 2013
Priority date	—
Expiry date	Jun 14, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P33/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Administration of at least one compound of the family of the avermectins or of the family of the milbemycins, notably ivermectin, is useful for the treatment of ophthalmic pathologies, including ocular rosacea.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.